Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis.
about
'Blood doping' from Armstrong to prehabilitation: manipulation of blood to improve performance in athletes and physiological reserve in patientsHIF hydroxylase pathways in cardiovascular physiology and medicineMetabolic control of dendritic cell activation and function: recent advances and clinical implicationsProlyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase.Intolerability of cobalt salt as erythropoietic agent.A Systems Pharmacology Model of Erythropoiesis in Mice Induced by Small Molecule Inhibitor of Prolyl Hydroxylase Enzymes.Maternal intestinal HIF-2α is necessary for sensing iron demands of lactation in miceTargeting the hypoxia-sensing pathway in clinical hematology.Current strategies of blood doping detection.Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.Regulation of wound healing and fibrosis by hypoxia and hypoxia-inducible factor-1.Role of Intestinal HIF-2α in Health and Disease.Interlaboratory trial for the measurement of total cobalt in equine urine and plasma by ICP-MS.Hypoxia in Atherogenesis.New renal anemia drugs: is there really anything new on the horizon?Increased Oxidative Stress and Hypoxia Inducible Factor-1 Expression during Arteriovenous Fistula Maturation.Intelligence-based anti-doping from an equine biological passport.lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers.Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls.Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
P2860
Q26765195-92E0769D-67E4-4C44-A436-B457D43C2158Q26862091-01356CAC-EAC8-4C84-88B2-2462FCC63E06Q28385947-63C82F14-DA5B-4CCD-B134-0B7414A25995Q33850553-A349557C-2DA1-43CD-B0D5-8E05BED1DF66Q34038171-AE77DED4-F639-41AD-A2EF-5BF8CC831F9DQ35179547-F542CCAE-E3F2-41BA-A74B-0EFEF1B49437Q35865706-1C819A2A-F016-43C8-AC38-C2A85041567BQ37585456-4044CEA4-A1E3-4CA3-9481-A4B644B6113DQ38128215-F43E91A8-5F42-4132-A1B8-8566D821E696Q38134288-860D52F3-6C3E-4608-B92A-A37BE34A5E37Q38222586-7C15B51D-E1D5-4C32-9E3F-17C8F262A539Q38669208-61FF4B67-BCB4-4B9F-ABE2-BA1A786128E2Q38893202-888ABC1F-EE85-419B-AA82-A3BF5FBD4041Q38939115-43C68A79-67F1-411A-A304-DEEBD3C46DDCQ44405723-36020E53-1D58-4486-9E93-5AF46FD78006Q46422995-9B755BB9-8FE7-48D9-A019-1C1D46D23359Q48156612-0D40BF41-B510-40C3-AEF5-48964F953CBAQ48319000-FFF690A5-CBFB-42A8-95DA-89B4EFD9A7F4Q49176400-0D1F070B-6FD1-4487-88C9-0D92F04FE037Q50052760-0E5AC1BD-3D7F-4226-AE49-91221EF3450AQ51679830-F9B21764-C304-4814-A8FC-E58C7BE96856Q53354414-1ED2EE7D-86D1-4CB2-BFC3-61F2D7F8AB08
P2860
Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@ast
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@en
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@nl
type
label
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@ast
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@en
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@nl
prefLabel
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@ast
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@en
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@nl
P356
P1476
Hypoxia-inducible factor stabi ...... nd preventive doping analysis.
@en
P2093
Simon Beuck
P2860
P304
P356
10.1002/DTA.390
P577
2012-02-24T00:00:00Z